Antihypertensive efficacy of treatment regimens used in veterans administration hypertension clinics

Hypertension

Volumn 31, Issue 3, 1998, Pages 771-779

  Perry Jr , H Mitchell ^a,b   Bingham, Stephen ^a   Horney, Anne ^a   Rutan, Gale ^a   Sambhi, Mohinder ^a   Carmody, Sharon ^a   Collins, Joseph ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Drug efficacy; Race; Target organ damage

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DRUG CHOICE; DRUG EFFICACY; DRUG USE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NEGRO; PATIENT CODING; PRIORITY JOURNAL; SOLDIER; TARGET ORGAN;

EID: 0344222183     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.3.771     Document Type: Article

References (14)

1. Perry HM Jr, Schnaper HW, Meyer G, Swatzell R. Clinical program for screening and treatment of hypertension in veterans. J Nat Med Assoc. 1982; 74:433-444.
2. Carlson JH, Perry AG. Hypertension Specialist Training Program. 1979. US Government Printing Office 0-311-644/3253.
3. Perry HM Jr, Belton ED, Moses C, Moss WG, Page IR, Smith WM, Sokolow M, Witwer BD. National High Blood Pressure Education Program. Report to the Hypertension Information and Education Advisory Committee, Task Force I Data Base. 1973. US Dept of Health, Education, and Welfare Publication No. (NIH) 74-593.
4. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154-183.
5. Perry HM Jr, Gillespie KN, Romeis JC, Smith MM, Virgo KS, Carmody SE, Sambhi MP. Effects of 'stroke belt' residence, screening blood pressures, and personal history risk factors on all-cause mortality among hypertensive veterans. J Hypertens. 1994;12:315-321.
6. Miller JP, Perry HM Jr, Rossiter JE, Baty JD, Carmody SE, Sambhi MP. Regional differences in mortality during 15-year follow-up of 11 936 hypertensive veterans. Hypertension. 1994;23:431-438.
7. Perry HM Jr, Carmody SE, Virgo K. Relation of ten-year mortality to early visit compliance and early treated diastolic pressure for 5522 hypertensive men. Hypertension. 1991;17:441. Abstract.
8. Perry HM, Miller JP, Fornoff JE, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE. Pretreatment characteristics and early treated blood pressures associated with development of end-stage renal disease in hypertensive men during 15 years of follow-up. Hypertension. 1995;25: 587-594.
9. Stason WB, Shepard DS, Perry HM Jr, Carmen BM, Nagurney JT, Rosner B, Meyer G. Effectiveness and costs of veterans affairs hypertension clinics. Med Care. 1994;32:1197-1215.
10. Shepard DS, Stason WB, Perry HM, Carmen BM, Nagurney JT. Multi-variate cost-effectiveness analysis: an application to optimizing ambulatory care for hypertension. Inquiry. 1995;32:320-331.
11. Prineas RJ, Crow R, Blackburn H. Minnesota Code Manual of Electrocardiographic Findings. Littlejohn, MS: John Wright-PSG; 1982.
12. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM, for the ALLHAT Research Group. Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). Am J Hypertens. 1996;9:342-360.
13. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, Hamburger RJ, Fye C, Lakshman R, Gottdiener J, Ramirez EA, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Single-drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med. 1993;328:914-921.
14. Materson BJ, Reda DJ, Cushman WC, Henderson WG, for the Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Results of combination antihypertensive therapy after failure of each of the components. J Hum Hypertens. 1995;9:791-796.